retatrutide joint pain shows substantial weight loss and relief in obesity and OA patients | Andrew J. Sauer, MD posted on the topic Lilly's retatrutide shows solid weight

Nausea, diarrhea, and vomiting were the most common complaints, occurring primarily during dose escalation periods

Glucagon normally tells your liver to release stored sugar

Another positive finding was seen in 60 patients with BED and T2DM when dulaglutide, which is not currently licensed for obesity, was compared with placebo at 12 weeks 222

If you change your behavior as well, you might have better luck at avoiding regain

Most individuals experience nausea that peaks in the first few days after a dose and diminishes before the next injection

Zepbound is approved for use by those who have a body mass index (BMI) of 30 or higher